![The Role of RWD in the Development of Remdesivir](https://d38uvx7mib76ry.cloudfront.net/public/images/IL8IvVWmuIW0UmZ1HbwREGXK6SBG8ZFKaMH54p5f.png)
Summary:
In this podcast, you will hear how Gilead designed, developed and obtained emergency-use authorization and full approval for remdesivir as treatment of COVID-19 in record time, plus the new capabilities they built to do so, the role of real world data and communicating with regulators. This session is from the 2021 DPHARM conference.
For more information on DPHARM: Disruptive Innovations to Modernize Clinical Research, visit DPHARMconference.com.
Related Podcasts
View All![Preferences in Decentralization and Digitalization of Pediatric Clinical Trials: Case Study](https://d38uvx7mib76ry.cloudfront.net/public/images/KRCjqX07kLJ0SL4dvkzKWHu2k4zTF6KJRldzVB8V.png)
Preferences in Decentralization and Digitalization of Pediatric Clinical Trials: Case Study
![Optimizing the Integration of Mobile, Patient-Facing Technologies in Clinical Trials for Accessibility and Flexibility](https://d38uvx7mib76ry.cloudfront.net/public/images/QvF6WsV1McmJEIl7xaQnVJszPxkclRJpeMahwZtQ.png)
Optimizing the Integration of Mobile, Patient-Facing Technologies in Clinical Trials for Accessibility and Flexibility
![Delivering Exceptional Clinical Trial Experiences for Patients](https://d38uvx7mib76ry.cloudfront.net/public/images/T3xgX7ADqfhMees6nwfMIA39eY0LVFEDaBMa04sd.png)
Delivering Exceptional Clinical Trial Experiences for Patients
![Measuring the Value of DCTs and Hybrid Models for Ultimate Trial Success](https://d38uvx7mib76ry.cloudfront.net/public/images/NpWjk0KiWqAvOIgFpl1XXajvZj7XbHjyVuXzwZNv.png)